Nucleic acid molecules

Patent metadata

Field	Value
Publication number	US-10131920-B2
Application number	US-201414775684-A
Country	US
Kind code	B2
Filing date	Mar 14, 2014
Priority date	Mar 15, 2013
Publication date	Nov 20, 2018
Grant date	Nov 20, 2018

Abstract

There is provided inter alia a DNA construct which comprises a tRNApyl coding sequence and a RNA polymerase III promoter sequence which is capable of acting to express functional tRNApyl sufficiently to support nonsense suppression in a eukaryotic expression system.

First claim

The invention claimed is:

1. A DNA construct which comprises a tRNApyl gene comprising a tRNApyl coding sequence comprising a functional intragenic RNA polymerase III promoter element comprising a putative A box, a putative B box, or a combination thereof, wherein the tRNApyl gene is capable of expressing functional tRNApyl sufficiently to support amber suppression in a eukaryotic expression system wherein the tRNApyl gene comprises a nucleic acid sequence selected from SEQ ID Nos 7, 8, 9, 10, and 11 derived from Methanosarcina mazei or a sequence of an analogous tRNApyl gene derived from another bacterial species which comprises 1 or 2 mutations in the putative A box, 1 or 2 mutations in the putative B box, or a combination thereof made in positions equivalent to A10G, A52C, T14A, or a combination thereof as shown in SEQ ID Nos 7, 8, 9, 10, or 11, wherein the mutations result in the generation of the functional intragenic promoter element.

2. A DNA construct according to claim 1 comprising a terminator sequence which is downstream of the tRNApyl coding sequence.

3. A DNA construct according to claim 1 wherein the tRNApyl coding sequence is operably linked to a 5′ promoter element comprising a RNA polymerase III promoter placed 5′ to the tRNApyl coding sequence.

4. A DNA construct according to claim 3 wherein the 5′ promoter element and the tRNApyl coding sequence are separated by a spacer sequence containing a transcriptional start site.

5. A DNA construct according to claim 1 which comprises the functional intragenic RNA polymerase III promoter element and a 5′ promoter element comprising a RNA polymerase III promoter sequence placed 5′ to the tRNApyl coding sequence such that the intragenic promoter element and the 5′ promoter element constitute a hybrid promoter.

6. A DNA construct according to claim 5 wherein the 5′ promoter element is a 5′ element of a Type 4 RNA polymerase III promoter.

7. A DNA construct according to claim 6 wherein the 5′ promoter element of the Type 4 RNA Polymerase III promoter is selected from:
(a) 5′ promoter elements of an EBER RNA gene promoter,
(b) a 7SL RNA gene promoter,
(c) a Vault RNA gene promoter; and
(d) SEQ ID Nos 12, 20, 26, 57, 58, 59, 60, 61, 62, 63, 64 and 65.

8. A DNA construct according to claim 7 wherein the 5′ promoter element of the Type 4 RNA Polymerase III promoter is a 7SL RNA gene promoter and wherein the DNA construct further comprises a spacer sequence selected from SEQ ID NOs 13 and 21.

9. A DNA construct according to claim 7 wherein the 5′ promoter element is selected from SEQ ID Nos 12, 20, 26, 57, 58, 59, 60, 61, 62, 63, 64 and 65.

10. A DNA construct according to claim 5 wherein the 5′ promoter element and the tRNApyl coding sequence are separated by a spacer sequence containing a transcriptional start site, and wherein the DNA construct further comprises a PylRS coding sequence or gene.

11. A multimeric DNA construct comprising multiple copies of the DNA construct according to claim 1 .

12. A DNA construct according to claim 1 which further comprises a PylRS coding sequence or gene.

13. A DNA construct according to claim 1 , wherein the mutations in the 1 or 2 nucleotide positions of the putative A box, the putative B box, or combinations thereof are selected from: (a) A10G, T14A, A52C, and combinations thereof in a tRNApyl gene from Methanosarcina mazei (SEQ ID NO: 3), and (b) mutations in positions equivalent to A10G, T14A and A52C in an analogous tRNApyl gene derived from another bacterial species selected from the group consisting of Methanosarcina barkeri (SEQ ID NO: 1), Desulfitobacterium hafniense (SEQ ID NO: 5), Methanosarcina acetivorans (SEQ ID NO: 2), Methanosarcina burtonii (SEQ ID NO: 4) and Methanosarcina thermophila.

14. A eukaryotic cell line comprising the DNA construct of claim 1 , wherein the eukaryotic cell line expresses functional PylRS and functional tRNApyl in which functional tRNApyl expression occurs under the control of the intragenic promoter element and a 5′ promoter element comprising a RNA polymerase III promoter element placed 5′ to the tRNApyl coding sequence such that the intragenic promoter element and 5′ promoter element constitute a hybrid promoter sufficient to support amber suppression.

15. A process for preparing a target protein containing one or more non-natural amino acids encoded by an amber codon which comprises expressing said target protein in a eukaryotic cell line which is transformed with a gene encoding said target protein and the DNA construct according to claim 1 , such that tRNApyl is expressed and functions sufficiently to support amber suppression.

16. A process for preparing a chemically modified target protein which comprises preparing a target protein according to the process of claim 15 and chemically modifying the resultant target protein.

17. A process according to claim 15 wherein at least one of the non-natural amino acids comprises an alkyne or azide moiety.

Assignees

• Medimmune Ltd

Inventors

• Dieci Giorgio
• Marelli Marcello
• Grabstein Kenneth H

Classifications

• C12N15/67 Primary

  General methods for enhancing the expression · CPC title

• C12P21/00

  Preparation of peptides or proteins (single cell protein C12N1/00) · CPC title

• C12N15/85 Primary

  for animal cells · CPC title

• C12N2800/107

  for mammalian · CPC title